ESSA Pharma Inc. (EPIX): Price and Financial Metrics

ESSA Pharma Inc. (EPIX): $5.30

0.06 (-1.12%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

Add EPIX to Watchlist
Sign Up

EPIX Price/Volume Stats

Current price $5.30 52-week high $6.40
Prev. close $5.36 52-week low $2.29
Day low $5.16 Volume 42,900
Day high $5.61 Avg. volume 128,727
50-day MA $4.37 Dividend yield N/A
200-day MA $3.29 Market Cap 233.74M

EPIX Stock Price Chart Interactive Chart >


ESSA Pharma Inc. (EPIX) Company Bio


ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is based in Vancouver, Canada.


EPIX Latest News Stream


Event/Time News Detail
Loading, please wait...

EPIX Latest Social Stream


Loading social stream, please wait...

View Full EPIX Social Stream

Latest EPIX News From Around the Web

Below are the latest news stories about ESSA PHARMA INC that investors may wish to consider to help them evaluate EPIX as an investment opportunity.

Director Franklin Berger Bolsters Position in ESSA Pharma Inc with Purchase of 23,259 Shares

Recent insider trading activity has caught the attention of market analysts and investors alike, as Director Franklin Berger executed a significant purchase of shares in ESSA Pharma Inc (NASDAQ:EPIX).

Yahoo | November 23, 2023

ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Piper Sandler 35th Annual Healthcare Conference on Thursday, November 30, 2023, at 12:00 p.m. ET in New York.

Yahoo | November 21, 2023

ESSA Pharma to Present at the Jefferies London Healthcare Conference

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the Jefferies Healthcare Conference on Wednesday, November 15, 2023, at 8:30 a.m. GMT/ 3:30 a.m. ET in London.

Yahoo | November 8, 2023

ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement

ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that it has entered into an Open Market Sale AgreementSM (the "ATM Sales Agreement") with Jefferies LLC, effective as of November 3, 2023. Under the ATM Sales Agreement, ESSA may sell its common shares in the capital of the Company from time to time for up to US$50.0 million in aggregate sales proceeds. No

Yahoo | November 6, 2023

We Think ESSA Pharma (NASDAQ:EPIX) Can Afford To Drive Business Growth

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Yahoo | October 31, 2023

Read More 'EPIX' Stories Here

EPIX Price Returns

1-mo -11.67%
3-mo 85.31%
6-mo 67.19%
1-year 52.74%
3-year -21.25%
5-year 100.76%
YTD 110.32%
2022 -82.25%
2021 19.03%
2020 116.91%
2019 161.90%
2018 -52.05%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!